About Us | Contact

Richard C Ahrens Investigator

Pediatric Allergy/Immunology NPI1144216722
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$296,880.21
from 15 payments in the last 6 years

Total Cash or Cash Equivalent

$294,168.68
from 5 payments in the last 6 years

Total In-kind Items & Services

$2,711.53
from 10 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
08/16/2018 General (Non-Research) In-kind items and services Food and Beverage $179.73 Details
Payment from Perrigo Company plc
Payment Record ID 544153803
08/16/2018 General (Non-Research) In-kind items and services Food and Beverage $10.23 Details
Payment from Perrigo Company plc
Payment Record ID 544153799
10/02/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $30892.50 Details
Payment from Perrigo Company plc
Payment Record ID 544153777
04/08/2016 Research Cash or cash equivalent Drug $255636.18 Details
Payment from Cipla USA Inc.
Paymment Research Study A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Four Way Crossover Multicenter Study to Compare the Bronchoprotective Effects of the Test Product Albuterol Sulfate HFA pMDI
Payment Record ID 512797615
12/14/2017 Research Cash or cash equivalent Drug $1000.00 Details
Payment from Cipla USA Inc.
Paymment Research Study A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Four Way Crossover Multicenter Study to Compare the Bronchoprotective Effects of the Test Product Albuterol Sulfate HFA pMDI
Payment Record ID 512126581
10/12/2016 General (Non-Research) In-kind items and services Travel and Lodging $209.00 Details
Payment from Teva Pharmaceuticals USA, Inc.
Payment Record ID 414276141
10/12/2016 General (Non-Research) In-kind items and services Travel and Lodging $2.54 Details
Payment from Teva Pharmaceuticals USA, Inc.
Payment Record ID 414276139
10/12/2016 General (Non-Research) In-kind items and services Food and Beverage $198.70 Details
Payment from Teva Pharmaceuticals USA, Inc.
Payment Record ID 414276137
10/13/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $3000.00 Details
Payment from Teva Pharmaceuticals USA, Inc.
Payment Record ID 414276135
10/27/2016 General (Non-Research) In-kind items and services Food and Beverage $19.89 Details
Payment from Gilead Sciences Inc
Payment Record ID 390961484
05/24/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $3640.00 Details
Payment from Gilead Sciences Inc
Payment Record ID 390215622
10/01/2016 General (Non-Research) In-kind items and services Education $314.00 Details
Payment from Mylan Specialty L.P.
Payment Record ID 383768280
12/01/2016 General (Non-Research) In-kind items and services Education $702.24 Details
Payment from Mylan Specialty L.P.
Payment Record ID 383648842
12/01/2016 General (Non-Research) In-kind items and services Education $373.20 Details
Payment from Mylan Specialty L.P.
Payment Record ID 383648836
10/01/2016 General (Non-Research) In-kind items and services Education $702.00 Details
Payment from Mylan Specialty L.P.
Payment Record ID 383648302
;